Next Financial Group’s Mustang Bio MBIO Stock Holding History

Next Financial Group’s Portfolio MBIO Stock Details MBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1	Closed	-$3K	–	2667
2021 Q1	$3K	Buy	+1	New	+$2.97K	﹤0.01%	2235

Other funds holding MBIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Next Financial Group's MBIO Position: Q2 2021 in Review

Next Financial Group sold out of Mustang Bio (MBIO) in Q2 2021, closing a stake of 1 share — an estimated $3K sold.

Next Financial Group first reported a position in MBIO in Q1 2021 and held it in 1 quarter. The position peaked at $3K in Q1 2021. 92 funds tracked by Wall St. Rank hold MBIO as of Q2 2021.

Next Financial Group reported no remaining Mustang Bio position as of Q2 2021 after selling out during the quarter.
Next Financial Group sold 1 Mustang Bio share in Q2 2021, an estimated $3K.
Next Financial Group first reported a position in Mustang Bio in Q1 2021 and held it in 1 quarter.
Next Financial Group's Mustang Bio position peaked at $3K in Q1 2021.
92 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2021.

Based on Next Financial Group's 13F filing for Q2 2021, filed 13 Jul 2021.